We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWR icon
2826
Westwater Resources
WWR
$77.3M
$37K ﹤0.01%
45,000
-66,000
-59% -$58.5K
PHLT
2827
DELISTED
Performant Healthcare Inc
PHLT
$37K ﹤0.01%
+13,669
New +$39.6K
ATHX
2828
DELISTED
Athersys, Inc. Common Stock
ATHX
$37K ﹤0.01%
42,376
KLTR icon
2829
Kaltura
KLTR
$243M
$36K ﹤0.01%
+16,888
New +$31.4K
CTV
2830
DELISTED
Innovid Corp.
CTV
$36K ﹤0.01%
32,640
+19,341
+145% +$20.1K
BNGO icon
2831
Bionano Genomics
BNGO
$13.3M
$35K ﹤0.01%
95
-92
-49% -$41.5K
HUMA icon
2832
Humacyte
HUMA
$167M
$35K ﹤0.01%
12,004
TDUP icon
2833
ThredUp
TDUP
$410M
$34K ﹤0.01%
13,830
+3,025
+28% +$7.92K
EMBK
2834
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$34K ﹤0.01%
11,775
LU icon
2835
Lufax Holding
LU
$1.31B
$33K ﹤0.01%
5,700
+2,150
+61% +$14.2K
VHC icon
2836
VirnetX Holding Corp
VHC
$67.6M
$33K ﹤0.01%
3,450
-2,435
-41% -$29.9K
SKYX icon
2837
SKYX Platforms
SKYX
$152M
$31K ﹤0.01%
+11,567
New +$37.1K
VERU icon
2838
Veru
VERU
$45.5M
$31K ﹤0.01%
2,530
-2,737
-52% -$32.1K
RAD
2839
DELISTED
Rite Aid Corporation
RAD
$30K ﹤0.01%
19,380
-62,123
-76% -$124K
BARK icon
2840
BARK
BARK
$95.9M
$29K ﹤0.01%
1,077
SCWO icon
2841
374Water
SCWO
$46.4M
$29K ﹤0.01%
+1,206
New +$38.5K
LLAP
2842
DELISTED
Terran Orbital Corporation
LLAP
$28K ﹤0.01%
+18,230
New +$28.9K
MMAT
2843
DELISTED
Meta Materials Inc. Common Stock
MMAT
$28K ﹤0.01%
1,293
-926
-42% -$22.3K
CAMP
2844
DELISTED
CalAmp Corp.
CAMP
$28K ﹤0.01%
1,109
SLGCW
2845
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$28K ﹤0.01%
111,700
-4,970
-4% -$1.79K
SPPI
2846
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$28K ﹤0.01%
28,305
CRGE
2847
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$27K ﹤0.01%
26,875
+1,510
+6% +$1.53K
BRDS
2848
DELISTED
Bird Global, Inc.
BRDS
$26K ﹤0.01%
12,548
-1,144
-8% -$3.6K
WULF icon
2849
TeraWulf
WULF
$8.42B
$25K ﹤0.01%
14,107
PSTX
2850
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$25K ﹤0.01%
+13,831
New +$35.3K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.